A citation-based method for searching scientific literature

T Baert, A Ferrero, J Sehouli, D M O'Donnell, A González-Martín, F Joly, J van der Velden, P Blecharz, D S P Tan, D Querleu, N Colombo, A du Bois, J A Ledermann. Ann Oncol 2021
Times Cited: 4







List of co-cited articles
10 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.
Antonio González-Martín, Bhavana Pothuri, Ignace Vergote, René DePont Christensen, Whitney Graybill, Mansoor R Mirza, Colleen McCormick, Domenica Lorusso, Paul Hoskins, Gilles Freyer,[...]. N Engl J Med 2019
384
75

Ovarian cancer statistics, 2018.
Lindsey A Torre, Britton Trabert, Carol E DeSantis, Kimberly D Miller, Goli Samimi, Carolyn D Runowicz, Mia M Gaudet, Ahmedin Jemal, Rebecca L Siegel. CA Cancer J Clin 2018
957
50

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
50

Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.
Kathleen Moore, Nicoletta Colombo, Giovanni Scambia, Byoung-Gie Kim, Ana Oaknin, Michael Friedlander, Alla Lisyanskaya, Anne Floquet, Alexandra Leary, Gabe S Sonke,[...]. N Engl J Med 2018
775
50

Changes in ovarian cancer survival during the 20 years before the era of targeted therapy.
Jung-Yun Lee, Sunghoon Kim, Young Tae Kim, Myong Cheol Lim, Boram Lee, Kyu-Won Jung, Jae Weon Kim, Sang-Yoon Park, Young-Joo Won. BMC Cancer 2018
38
50

Fifth Ovarian Cancer Consensus Conference: individualized therapy and patient factors.
J McGee, M Bookman, P Harter, C Marth, I McNeish, K N Moore, A Poveda, F Hilpert, K Hasegawa, M Bacon,[...]. Ann Oncol 2017
29
50

Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer.
Isabelle Ray-Coquard, Patricia Pautier, Sandro Pignata, David Pérol, Antonio González-Martín, Regina Berger, Keiichi Fujiwara, Ignace Vergote, Nicoletta Colombo, Johanna Mäenpää,[...]. N Engl J Med 2019
304
50

Safety and Antitumor Activity of Anti-PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer.
Junzo Hamanishi, Masaki Mandai, Takafumi Ikeda, Manabu Minami, Atsushi Kawaguchi, Toshinori Murayama, Masashi Kanai, Yukiko Mori, Shigemi Matsumoto, Shunsuke Chikuma,[...]. J Clin Oncol 2015
606
50

PARP inhibitors: Synthetic lethality in the clinic.
Christopher J Lord, Alan Ashworth. Science 2017
876
50


Maximal-Effort Cytoreductive Surgery for Ovarian Cancer Patients with a High Tumor Burden: Variations in Practice and Impact on Outcome.
Marcia Hall, Konstantinos Savvatis, Katherine Nixon, Maria Kyrgiou, Kuhan Hariharan, Malcolm Padwick, Owen Owens, Paula Cunnea, Jeremy Campbell, Alan Farthing,[...]. Ann Surg Oncol 2019
24
25

Patient Perception of Telehealth Services for Breast and Gynecologic Oncology Care during the COVID-19 Pandemic: A Single Center Survey-based Study.
Brittney S Zimmerman, Danielle Seidman, Natalie Berger, Krystal P Cascetta, Michelle Nezolosky, Kara Trlica, Alisa Ryncarz, Caitlin Keeton, Erin Moshier, Amy Tiersten. J Breast Cancer 2020
13
25

Contraceptive methods and ovarian cancer risk among Chinese women: A report from the Shanghai Women's Health Study.
Zhezhou Huang, Yutang Gao, Wanqing Wen, Honglan Li, Wei Zheng, Xiao-Ou Shu, Alicia Beeghly-Fadiel. Int J Cancer 2015
20
25

Response rates to second-line platinum-based therapy in ovarian cancer patients challenge the clinical definition of platinum resistance.
Kristina Lindemann, Bo Gao, Cristina Mapagu, Sian Fereday, Catherine Emmanuel, Kathryn Alsop, Nadia Traficante, Paul R Harnett, David D L Bowtell, Anna deFazio. Gynecol Oncol 2018
15
25

Radiation for persistent or recurrent epithelial ovarian cancer: a need for reassessment.
Noorie Choi, Ji Hyun Chang, Suzy Kim, Hak Jae Kim. Radiat Oncol J 2017
10
25

Management of the adnexal mass.
James H Liu, Kristine M Zanotti. Obstet Gynecol 2011
34
25

Pathology of Hereditary Breast and Ovarian Cancer.
Anjelica Hodgson, Gulisa Turashvili. Front Oncol 2020
8
25

FDA Approval Summary: Rucaparib for the Treatment of Patients with Deleterious BRCA Mutation-Associated Advanced Ovarian Cancer.
Sanjeeve Balasubramaniam, Julia A Beaver, Sara Horton, Laura L Fernandes, Shenghui Tang, Hisani N Horne, Jinzhong Liu, Chao Liu, Sarah J Schrieber, Jingyu Yu,[...]. Clin Cancer Res 2017
71
25

Ovarian Cancer in Hereditary Cancer Susceptibility Syndromes.
Quentin B Nakonechny, C Blake Gilks. Surg Pathol Clin 2016
14
25

Mutations in BRCA1, BRCA2 and other breast and ovarian cancer susceptibility genes in Central and South American populations.
Lilian Jara, Sebastian Morales, Tomas de Mayo, Patricio Gonzalez-Hormazabal, Valentina Carrasco, Raul Godoy. Biol Res 2017
17
25

Practice guidelines for management of ovarian cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement.
Dong Hoon Suh, Suk Joon Chang, Taejong Song, Sanghoon Lee, Woo Dae Kang, Sun Joo Lee, Ju Won Roh, Won Duk Joo, Joo Hee Yoon, Dae Hoon Jeong,[...]. J Gynecol Oncol 2018
8
25

Occupational exposure to carcinogens: Benzene, pesticides and fibers (Review).
Luca Falzone, Andrea Marconi, Carla Loreto, Sabrina Franco, Demetrios A Spandidos, Massimo Libra. Mol Med Rep 2016
33
25

Benefits from specialised cancer care.
P Selby, C Gillis, R Haward. Lancet 1996
122
25

Gynecologic cancer surveillance in the era of SARS-CoV-2 (COVID-19).
Gemma Mancebo, Josep-Maria Solé-Sedeño, Ismael Membrive, Alvaro Taus, Marta Castells, Laia Serrano, Ramon Carreras, Ester Miralpeix. Int J Gynecol Cancer 2021
4
25

Epidemiological and genetic factors associated with ovarian cancer.
Monica R McLemore, Christine Miaskowski, Bradley E Aouizerat, Lee-May Chen, Marylin J Dodd. Cancer Nurs 2009
30
25


Histologic, molecular, and cytogenetic features of ovarian cancers: implications for diagnosis and treatment.
Neeraj Lalwani, Srinivasa R Prasad, Raghunandan Vikram, Alampady K Shanbhogue, Phyllis C Huettner, Najla Fasih. Radiographics 2011
88
25

Bevacizumab combined with platinum-taxane chemotherapy as first-line treatment for advanced ovarian cancer: a prospective observational study of safety and efficacy in Japanese patients (JGOG3022 trial).
Shinichi Komiyama, Kazuyoshi Kato, Yuki Inokuchi, Hirokuni Takano, Takashi Matsumoto, Atsushi Hongo, Mikiko Asai-Sato, Atsushi Arakawa, Shoji Kamiura, Tsutomu Tabata,[...]. Int J Clin Oncol 2019
24
25

The impacts of neoadjuvant chemotherapy and of cytoreductive surgery on 10-year survival from advanced ovarian cancer.
Soyoun Rachel Kim, Joanne Kotsopoulos, Ping Sun, Marcus Q Bernardini, Stephane Laframboise, Sarah E Ferguson, Barry Rosen, Steven A Narod, Taymaa May. Int J Gynaecol Obstet 2021
1
100

Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial.
Jonathan Ledermann, Philipp Harter, Charlie Gourley, Michael Friedlander, Ignace Vergote, Gordon Rustin, Clare L Scott, Werner Meier, Ronnie Shapira-Frommer, Tamar Safra,[...]. Lancet Oncol 2014
850
25

Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients.
F Stephen Hodi, Marcus Butler, Darryl A Oble, Michael V Seiden, Frank G Haluska, Andrea Kruse, Suzanne Macrae, Marybeth Nelson, Christine Canning, Israel Lowy,[...]. Proc Natl Acad Sci U S A 2008
470
25

A population-based analysis of germline BRCA1 and BRCA2 testing among ovarian cancer patients in an era of histotype-specific approaches to ovarian cancer prevention.
Gillian E Hanley, Jessica N McAlpine, Dianne Miller, David Huntsman, Kasmintan A Schrader, C Blake Gilks, Gillian Mitchell. BMC Cancer 2018
10
25

Prognostic values of DNA mismatch repair genes in ovarian cancer patients treated with platinum-based chemotherapy.
Chuchu Zhao, Saisai Li, Menghuang Zhao, Haiyan Zhu, Xueqiong Zhu. Arch Gynecol Obstet 2018
15
25

Variation in the initial assessment and investigation for ovarian cancer in symptomatic women: a systematic review of international guidelines.
Garth Funston, Marije Van Melle, Marie-Louise Ladegaard Baun, Henry Jensen, Charles Helsper, Jon Emery, Emma J Crosbie, Matthew Thompson, Willie Hamilton, Fiona M Walter. BMC Cancer 2019
8
25

Diet quality and survival after ovarian cancer: results from the Women's Health Initiative.
Cynthia A Thomson, Tracy E Crane, Betsy C Wertheim, Marian L Neuhouser, Wenjun Li, Linda G Snetselaar, Karen M Basen-Engquist, Yang Zhou, Melinda L Irwin. J Natl Cancer Inst 2014
35
25

Multigene panel analysis identified germline mutations of DNA repair genes in breast and ovarian cancer.
Yosuke Hirotsu, Hiroshi Nakagomi, Ikuko Sakamoto, Kenji Amemiya, Toshio Oyama, Hitoshi Mochizuki, Masao Omata. Mol Genet Genomic Med 2015
55
25


Comparison of diagnostic values between CA125 combined with CA199 and ultrasound combined with CT in ovarian cancer.
Bingcheng Guo, Wei Lian, Shuai Liu, Yingchun Cao, Jianhua Liu. Oncol Lett 2019
7
25

Immunological effects of occupational exposure to lead (Review).
Concettina Fenga, Silvia Gangemi, Valentina Di Salvatore, Luca Falzone, Massimo Libra. Mol Med Rep 2017
37
25


Specialized and high-volume care leads to better outcomes of ovarian cancer treatment in the Netherlands.
Flora Vernooij, A Peter M Heintz, Jan-Willem Coebergh, Leon F A G Massuger, Petronella O Witteveen, Yolanda van der Graaf. Gynecol Oncol 2009
84
25

Association of Hospital Volume and Quality of Care With Survival for Ovarian Cancer.
Jason D Wright, Ling Chen, June Y Hou, William M Burke, Ana I Tergas, Cande V Ananth, Alfred I Neugut, Dawn L Hershman. Obstet Gynecol 2017
26
25

Analysis of hereditary cancer syndromes by using a panel of genes: novel and multiple pathogenic mutations.
Georgios N Tsaousis, Eirini Papadopoulou, Angela Apessos, Konstantinos Agiannitopoulos, Georgia Pepe, Stavroula Kampouri, Nikolaos Diamantopoulos, Theofanis Floros, Rodoniki Iosifidou, Ourania Katopodi,[...]. BMC Cancer 2019
22
25



Classification of Ovarian Cancer Surgery Facilitates Treatment Decisions in a Gynecological Multidisciplinary Team.
Signe Frahm Bjørn, Tine Henrichsen Schnack, Henrik Lajer, Ib Jarle Christensen, Lene Lundvall, Lotte Nedergaard Thomsen, Claus Høgdall. Int J Gynecol Cancer 2017
3
33

Immunohistochemical expression of TGF beta (TGF-β), TGF beta receptor 1 (TGFBR1), and Ki67 in intestinal variant of gastric adenocarcinomas.
Anca Oana Docea, P Mitruţ, Diana Grigore, D Pirici, Daniela Cornelia Călina, Eliza Gofiţă. Rom J Morphol Embryol 2012
16
25

Dietary intake and ovarian cancer risk: a systematic review.
Tracy E Crane, Beman R Khulpateea, David S Alberts, Karen Basen-Engquist, Cynthia A Thomson. Cancer Epidemiol Biomarkers Prev 2014
41
25

Intravenous aflibercept for treatment of recurrent symptomatic malignant ascites in patients with advanced ovarian cancer: a phase 2, randomised, double-blind, placebo-controlled study.
Walter H Gotlieb, Frederic Amant, Suresh Advani, Chanchal Goswami, Hal Hirte, Diane Provencher, Naresh Somani, S Diane Yamada, Jean-Francois Tamby, Ignace Vergote. Lancet Oncol 2012
97
25

Mutational analysis of STK11 gene in ovarian carcinomas.
Y Nishioka, K Kobayashi, S Sagae, M Sugimura, S Ishioka, M Nagata, K Terasawa, T Tokino, R Kudo. Jpn J Cancer Res 1999
18
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.